ClearView 3 SBL-3+21.75Recalls & reported problems
Lenstec Barbados Inc · Multifocal IOL modified plate, HEMA · Class 3 · Implant
All models of ClearView 3 (22)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00844369038379), received between Jan 12, 2023 and Apr 22, 2026 — classified as 4 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Insufficient Device Problem Information2
Patient problems
- Toxic Anterior Segment Syndrome (TASS)2
- Unspecified Eye / Vision Problem2
- Insufficient Information1
- Zonular Dehiscence1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryApr 22, 2026Adverse Event Without Identified Device or Use Problem
LENSTEC RECEIVED AN EMAIL STATING "SUSPECTED TASS SYMPTOMS.".
Patient problems: Toxic Anterior Segment Syndrome (TASS)
MAUDE report 24958207 ↗InjuryFeb 25, 2026Adverse Event Without Identified Device or Use Problem
LENSTEC RECEIVED AN EMAIL STATING "THE LENS WAS NOT PERFORMING AS BIFOCAL, TRIED TO REPOSITION IT-UNSUCCESSFUL."
Patient problems: Unspecified Eye / Vision Problem; Zonular Dehiscence
MAUDE report 24444750 ↗InjuryMar 14, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
LENSTEC RECEIVED AN EMAIL STATING "PATIENT DEVELOPED TASS SYMPTOMS AFTER SURGERY."
Patient problems: Toxic Anterior Segment Syndrome (TASS)
MAUDE report 21604904 ↗InjuryJan 12, 2023Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
LENSTEC RECEIVED AN EMAIL STATING "AFTER CATARACT SURGERY IN LEFT EYE OF PRECLINICAL PATIENTS WITH COMPARATIVE GLAUCOMA, THE FIRST DAY VISUAL ACUITY WAS 0.6. PUPILLARY EXUDATION APPEARED IN THE LEFT EYE NINE DAYS AFTER SURGERY. LENS REMAINS IMPLANTED AND NO REPORTED PATIENT INJURY."
Patient problems: Insufficient Information; Unspecified Eye / Vision Problem
MAUDE report 16152980 ↗
Other Lens, Multifocal Intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page